{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:51Z","timestamp":1790007291458,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02224-8","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:45:19Z","timestamp":1764233119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Migraine management in Chinese headache centers: a national survey and the role of quality control inspections"],"prefix":"10.1186","volume":"26","author":[{"given":"Ye","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"2224_CR1","unstructured":"GBD 2016 Headache Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954\u2013976"},{"key":"2224_CR2","doi-asserted-by":"crossref","unstructured":"Yu S, Liu R, Zhao G et al (2012) The Prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52(4):582\u2013591","DOI":"10.1111\/j.1526-4610.2011.02061.x"},{"key":"2224_CR3","doi-asserted-by":"crossref","unstructured":"Yu S, Zhang M, Zhou J et al (2014) Headache care in China. Headache 54(4):601\u2013609","DOI":"10.1111\/head.12330"},{"key":"2224_CR4","doi-asserted-by":"crossref","unstructured":"Dong Z, Chen X, Steiner TJ et al (2015) Medication-overuse headache in China: clinical profile, and an evaluation of the ichd-3 beta diagnostic criteria. Cephalalgia : an Int J Headache 35(8):644\u2013651","DOI":"10.1177\/0333102414552533"},{"key":"2224_CR5","doi-asserted-by":"crossref","unstructured":"Liu H, Dong M, Liu K et al (2023) Status of diagnosis and preventative treatment for primary headache disorders: real-world data of unmet needs in China. J Headache Pain 24(1):119","DOI":"10.1186\/s10194-023-01654-6"},{"key":"2224_CR6","doi-asserted-by":"crossref","unstructured":"Schramm S, Uluduz D, Gouveia RG et al (2016) Headache service quality: evaluation of quality indicators in 14 specialist-care centres. J Headache Pain 17(1):111","DOI":"10.1186\/s10194-016-0707-9"},{"key":"2224_CR7","doi-asserted-by":"publisher","first-page":"g1416","DOI":"10.1136\/bmj.g1416","volume":"348","author":"TJ Schwedt","year":"2014","unstructured":"Schwedt TJ (2014) Chronic migraine. BMJ: Br Med J 348:g1416","journal-title":"BMJ: Br Med J"},{"key":"2224_CR8","doi-asserted-by":"crossref","unstructured":"Schramm SH, Obermann M, Katsarava Z et al (2013) Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain 14(1):40","DOI":"10.1186\/1129-2377-14-40"},{"key":"2224_CR9","doi-asserted-by":"crossref","unstructured":"Katsarava Z, Buse D C, Manack A N et al (2012) Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep 16(1):86\u201392","DOI":"10.1007\/s11916-011-0233-z"},{"issue":"6","key":"2224_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1526-4610.2008.01135.x","volume":"48","author":"EA Schulman","year":"2008","unstructured":"Schulman EA, Brahin EJ (2008) Refractory headache: historical perspective, need, and purposes for an operational definition. Headache 48(6):770\u2013777","journal-title":"Headache"},{"key":"2224_CR11","doi-asserted-by":"crossref","unstructured":"Martelletti P, Katsarava Z, Lampl C et al (2014) Refractory chronic migraine: a consensus statement on clinical definition from the European headache federation. J Headache Pain 15(1):47","DOI":"10.1186\/1129-2377-15-47"},{"key":"2224_CR12","doi-asserted-by":"crossref","unstructured":"Sacco S, Braschinsky M, Ducros A et al (2020) European headache federation consensus on the definition of resistant and refractory migraine: developed with the endorsement of the European migraine & headache Alliance (emha). J Headache Pain 21(1):76","DOI":"10.1186\/s10194-020-01130-5"},{"key":"2224_CR13","doi-asserted-by":"crossref","unstructured":"Sacco S, Lampl C, Maassen van den Brink A et al (2021) Burden and attitude to resistant and refractory migraine: a survey from the European headache federation with the endorsement of the European migraine & headache Alliance. J Headache Pain 22(1):39","DOI":"10.1186\/s10194-021-01252-4"},{"key":"2224_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pmedr.2017.12.009","volume":"9","author":"H Takaki","year":"2018","unstructured":"Takaki H, Onozuka D, Hagihara A (2018) Migraine-Preventive prescription patterns by Physician specialty in ambulatory care settings in the United States. Prev Med Rep 9:62\u201367","journal-title":"Prev Med Rep"},{"key":"2224_CR15","doi-asserted-by":"crossref","unstructured":"Jackson JL, Kay C, Scholcoff C et al (2018) Migraine Prophylactic management in Neurology and Primary care (2006\u20132015). J Neurol 265(12):3019\u20133021","DOI":"10.1007\/s00415-018-9066-6"},{"key":"2224_CR16","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2147\/JPR.S453937","volume":"17","author":"G Berman","year":"2024","unstructured":"Berman G, Thiry A, Croop R (2024) Safety of Rimegepant in patients using preventive migraine medications: a subgroup analysis of a long-term, open-label study conducted in the United States. J Pain Res 17:1805\u20131814","journal-title":"J Pain Res"},{"key":"2224_CR17","doi-asserted-by":"crossref","unstructured":"Ezzati A, Fanning KM, Teichrow D et al (2025) Headache assessment via digital platform in United States: baseline study characteristics, diagnosis, and treatment patterns. Headache 65(8):1428\u20131438","DOI":"10.1111\/head.15016"},{"key":"2224_CR18","doi-asserted-by":"crossref","unstructured":"Multani JK, Urman R, Park AS et al (2025) Changes in use of acute and preventive medications for migraine after erenumab initiation over 12\u2009Months: a United States retrospective cohort study. Headache 65(1):68\u201379","DOI":"10.1111\/head.14820"},{"key":"2224_CR19","doi-asserted-by":"crossref","unstructured":"Croop R, Lipton RB, Kudrow D et al (2021) Oral rimegepant for preventive treatment of migraine: a phase 2\/3, randomised, double-blind, placebo-controlled trial. Lancet (London, England). 397(10268):51\u201360","DOI":"10.1016\/S0140-6736(20)32544-7"},{"key":"2224_CR20","doi-asserted-by":"crossref","unstructured":"Johnston K, Harris L, Powell L et al (2022) Monthly migraine days, tablet utilization, and quality of Life associated with rimegepant - post hoc results from an open label safety study (Bhv3000-201). J Headache Pain 23(1):10","DOI":"10.1186\/s10194-021-01378-5"},{"key":"2224_CR21","doi-asserted-by":"crossref","unstructured":"Anukoolwittaya P, Hiransuthikul A, Pongpitakmetha T et al (2024) Filling the Data gap on cgrp mab therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand. J Headache Pain 25(1):150","DOI":"10.1186\/s10194-024-01859-3"},{"issue":"12","key":"2224_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1468-2982.2005.00969.x","volume":"25","author":"Soon YY","year":"2005","unstructured":"Soon YY, Siow HC, Tan CY (2005) Assessment of Migraineurs referred to a Specialist headache clinic in Singapore: diagnosis, treatment strategies, outcomes, knowledge of migraine treatments and satisfaction. Cephalalgia: An Int J Headache 25(12):1122\u20131132","journal-title":"Cephalalgia: An Int J Headache"},{"key":"2224_CR23","doi-asserted-by":"crossref","unstructured":"Pressman AR, Buse DC, Jacobson AS et al (2021) The migraine signature study: methods and baseline results. Headache 61(3):462\u2013484","DOI":"10.1111\/head.14033"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02224-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02224-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02224-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:45:22Z","timestamp":1764233122000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02224-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02224-8","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Chinese PLA General Hospital (Approval No. 2023\u2013707-01), and all participating physicians provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}